Primary Care Clinics in Saint Stephen, SC Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 North Berkeley Family Care, Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 137 Cedar Dr, Saint Stephen, SC 29479 Phone: 843-567-4000 Fax: 843-567-3000 |
Palmetto Primary Care Physicians, Llc Family Medicine - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 Funk Ave, Saint Stephen, SC 29479 Phone: 843-567-3206 Fax: 843-567-3287 |
Family Practice Of St. Stephen, Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 Funk Ave, Saint Stephen, SC 29479 Phone: 843-567-3206 Fax: 843-567-3287 |
News Archive
Tamir's compounds perform better than Ganciclovir for Cytomegalovirus disease: Study
Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds outperformed market leader Roche's drug Ganciclovir in cell culture and plaque reduction assay (the gold standard) for Cytomegalovirus (CMV) disease. Additionally, antiviral activity was also apparent against other human herpesviruses, namely, HSV-1 (cold sores), HSV-2 (genital herpes), and Varicella-Zoster Virus (VZV) (chicken-pox and shingles).
HOXB13 and IL17BR genes predict outcome for breast cancer patients
The 2-gene expression profile of HOXB13 and IL17BR in a woman's breast cancer predicts risk of recurrence in node-negative patients treated with tamoxifen.
Young children picked up extra weight during the COVID-19 pandemic
A Kaiser Permanente study of nearly 200,000 children showed that children gained excess weight during the COVID-19 pandemic, especially those between 5 and 11 years old. The study was published in the Journal of the American Medical Association.
New drug delivery system by Renishaw hopes to aid Parkinson's treatment
Renishaw's novel drug delivery system, to be used in partnership with Herantis Pharma Plc's drug candidate CDNF for the treatment of Parkinson's disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union's Framework Programme for Research and Innovation.
Abbott to highlight latest investigational research findings on HUMIRA at EULAR 2012
Abbott scientists and independent researchers will highlight the latest investigational research findings on HUMIRA (adalimumab) at the European League Against Rheumatism (EULAR) Congress in Berlin, Germany, from 6-9 June, 2012.
› Verified 5 days ago